Abstract
Bacteria that reside in the gastrointestinal tract of healthy humans are essential for our health, sustenance and well-being. About 50–60% of those bacteria have the ability to produce resilient spores that are important for the life cycle in the gut and for host-to-host transmission. A genomic signature for sporulation in the human intestine was recently described, which spans both commensals and pathogens such as Clostridioides difficile and contains several genes of unknown function. We report on the characterization of a signature gene, CD25890, which, as we show is involved in the control of sporulation initiation in C. difficile under certain nutritional conditions. Spo0A is the main regulatory protein controlling entry into sporulation and we show that an in-frame deletion of CD25890 results in increased expression of spo0A per cell and increased sporulation. The effect of CD25890 on spo0A is likely indirect and mediated through repression of the sinRR´ operon. Deletion of the CD25890 gene, however, does not alter the expression of the genes coding for the cytotoxins or the genes involved in biofilm formation. Our results suggest that CD25890 acts to modulate sporulation in response to the nutrients present in the environment.
Subject terms: Microbiology, Bacteria, Microbial genetics, Pathogens
Introduction
Many members of the Firmicutes phylum produce endospores (hereafter spores for simplicity), as resilient and metabolically dormant structures that can remain viable for long periods of time. For anaerobic bacteria, the production of oxygen-resistant spores is an important mechanism for transmission between hosts and persistence inside and outside the host1. A large proportion of recently identified members of the human gut microbiota are spore formers, many of which are anaerobic1,2 and in rare cases can cause opportunistic infections1,3. Other spore formers, however, have evolved to become dedicated pathogens that can cause a variety of diseases for which the transmissible and infectious agent is often the spore. Toxins are produced by the actively growing cells that result from spore germination, highlighting the central role sporulation has in the pathophysiology of infection4. One example is Clostridioides difficile, an obligate anaerobic nosocomial pathogen and the major causative agent of a range of intestinal diseases associated with antibiotic therapy in adults5,6.
Entry into sporulation requires phosphorylation of the Spo0A response regulator. Spo0A is conserved amongst spore formers and is essential for sporulation initiation in all organisms in which its function has been experimentally assessed7–9. The activation and role of Spo0A in sporulation has been studied in detail in Bacillus subtilis10–14. Spo0A is activated via phosphorylation by a phosphorelay consisting of several sensor kinases and by the phosphortransfer proteins Spo0F and Spo0B. The kinases respond to external signals by auto-phosphorylating an histidine residue and subsequently transferring a phosphoryl group via the intermediary proteins Spo0F and Spo0B to Spo0A15. The phosphorelay provides multiple points of control of the flow of phosphate to Spo0A and serves to integrate several signals, including metabolic or from the cell cycle, that promote entry into sporulation under conditions of extreme nutrient deprivation in a cell density-dependent manner16. In contrast to B. subtilis, no Spo0F or Spo0B homologs are present in C. difficile; rather, Spo0A is believed to be phosphorylated directly by orphan histidine kinases that respond to unidentified signals17,18. The C. difficile genome codes for five predicted orphan kinases, three of which, CD14920, CD15790 and CD24920, share sequence similarity with the phosphorelay sensor kinases of B. subtilis18. These three kinases were initially proposed to be responsible for Spo0A phosphorylation, but only CD15790 was shown to directly phosphorylate Spo0A. While the role of CD24920 is still unclear18, CD14920 is known to inhibit sporulation initiation and to affect toxin and motility through the regulatory proteins RstA and SigD19.
Although our knowledge of the regulatory network that controls initiation of sporulation is still incomplete, evidence suggests that C. difficile may directly respond to the nutritional potential of the environment20. Two global regulators, CcpA and CodY, involved in nutrient sensing, downregulate sporulation by repressing the expression of genes required for sporulation under high-nutrient conditions21–24. When nutrients are abundant, CodY binds branched chain amino acids and GTP and acts primarily as a transcriptional repressor of alternative metabolic pathways22–24. CcpA in turn governs the global response to carbon availability21. Both regulators repress expression of the sinRR’ operon, which stimulates spo0A transcription and/or Spo0A activity25. The genome of C. difficile also encodes homologues of the B. subtilis Opp and App oligopeptide permeases, which in the latter organism are required for sporulation initiation26,27. In C. difficile, however, deletion of opp/app results in increased expression of the sinRR’ operon and increased sporulation20. Presumably, peptide uptake increases the intracellular availability of amino acids and the activity of CodY and CcpA20.
In C. difficile, Spo0A controls approximately 300 genes13,28, which have been linked to biofilm formation, swimming motility, toxin production and sporulation13,18,29. Among the latter, are the genes coding for the first cell type-specific regulators of sporulation (σF and σE) as well as genes required for asymmetric division13,16,30–32.
We previously established a genomic signature for sporulation, defined as the genes found in 90% of the endospore forming bacteria and present in no more than 10% of the non-endospore formers (7; Fig. S1A). This signature not only allows spore formation to be predicted for organisms for which sporulation has not been demonstrated in the laboratory, but also allows prediction of new genes potentially involved in the process7. More recently, a genomic signature for sporulation in the human gastro-intestinal tract was established (1; Fig. S1A). This signature includes 65 genes and is dominated by genes with a known function in sporulation. Approximately 30% of the signature genes, however, have no known function in sporulation and/or code for products with no similarity to known proteins1. Nevertheless, their presence in a genomic signature for sporulation suggests a role in spore development, at least in the gut. We show, that deletion of one of these genes, CD25890, increases sporulation as well as the expression of spo0A per cell, under certain nutritional conditions. We further show that the increased sporulation in the CD25890 mutant is associated with the differential expression of the sinRR’ operon, which was shown to be involved in sporulation, toxin production and motility. Deletion of the CD25890 gene, however, does not alter the production of the cytotoxin TcdA or biofilm formation. Together our results suggest that CD25890 negatively modulates sporulation under certain nutritional conditions.
Results
Deletion of the CD25890 gene
Although present in a genomic signature for endosporulation, the CD25890 gene has a broader distribution among eubacteria, and is found even in non-sporulating organisms (STRING database;33). For all Firmicutes genomes we examined, CD25890 is found immediately upstream of the gmk gene coding for a guanylate kinase, as in C. difficile, or of the remA gene encoding a biofilm regulator (34; Fig.S1B). These genes, in turn, are always upstream of the rpoZ gene, coding for the omega subunit of RNA polymerase. Although its genomic context is conserved, there is no evidence for the possible function of CD25890. CD25890 belongs to the YicC-like family which includes poorly characterized proteins that play a role in survival during stationary phase (35; Fig. 1A). These proteins have a C-terminal domain of unknown function (DUF1732). Structural modelling of this domain suggests that it may bind to nucleic acids (36; Fig. 1A).
To study the role of CD25890 in the physiology of C. difficile, we inactivated the CD25890 gene. An in-frame deletion mutant of CD25890, lacking codons 5–291 of the 293-codon open reading frame was generated by allelic-coupled exchange (ACE) in the background of the widely used 630erm strain (Fig. 1B; Fig. S2A and B; Table S5;37). The CD25890 deletion mutation did not affect the expression of the downstream gene gmk, as evidenced by qRT-PCR analysis (Fig. S2C). To allow complementation analysis, a single copy of CD25890 was inserted into the genome by ACE, upon restoration of the pyrE gene (Fig. S2A and B;37). In this strain, termed CD25890c, expression of the CD25890 gene is restored, although to levels ~ threefold lower than in the wild-type (Fig. S2C). The lower expression of CD25890 in the complemented strain may indicate that the gene is part of a large operon. In fact, previous work using genome-wide transcriptional start site (TSS) mapping, identified a unique TSS in this region, located 23 bp upstream of dapF (Fig. 1B). This suggests that dapF is the first gene of a large operon which includes CD2589038.
Impact of CD25890 deletion on biofilm formation, toxin production and sporulation
Since CD25890 belongs to the YicC-like family, and this family was reported to be involved in survival during stationary phase35, we started by determining whether the CD25890 mutation had an impact on toxin production, biofilm formation or sporulation, all of which are stationary phase processes. We first tested the ability of these strains to form a biofilm in the presence of glucose or glucose with deoxycholate (DOC), using the crystal violet assay39. We found no effect of the CD25890 mutation on the induction of biofilm formation in the presence of glucose alone or glucose with DOC after 24 h of growth (Fig. S3A).
We then used immunoblot analysis to investigate the levels of toxin (TcdA). The wild-type and the mutant strain were grown in TY, a medium that supports efficient toxin production40. Samples were collected 8, 10, 12 and 14 h after inoculation, and the presence of TcdA was monitored in the cell fractions. TcdA levels were similar in the wild type and CD25890 mutant strain (Fig. S3B).
For sporulation, we examined cultures of the CD25890 mutant after 14 h of incubation in sporulation liquid medium (SM). SM has been shown to induce sporulation in strain 630Δerm and is well suited for kinetic analyses and fluorescence microscopy41,42. The cells were stained with the lipophilic membrane dye FM4-64, which allows identification of the stages of sporulation up to engulfment completion, prior to imaging by phase-contrast and fluorescence microscopy41. As shown in Fig. S3C, the CD25890 mutant presents more cells with signs of sporulation than the wild-type strain or the complementation strain as determined by fluorescence and phase-contrast microscopy (630 erm, 29%; CD25890, 69%; CD25890C, 25%).
To rule out that the increased sporulation phenotype resulted from differences during vegetative growth, the wild-type and the CD25890 mutant strains were grown in SM and the optical density of the cultures was measured at 600 nm (OD600) at two-hour intervals for 20 h after inoculation. Both strains showed similar growth rates (wild-type 0.658 and CD25890 0.613) and, after about 10 h, both entered stationary phase (Fig. S3D). Therefore, the CD25890 mutation does not impact the growth of C. difficile under the conditions tested.
Disruption of CD25890 results in increased spore formation
To determine more precisely whether the CD25890 mutant sporulated more efficiently than the wild-type, the CD25890 mutant, wild-type, and the CD25890c complement strain were analysed for their ability to form heat resistant spores. Strains were grown in SM broth, and at 12, 24, 48 and 72 h the titer of heat resistant spores/ml of culture was determined as described in the Materials and Methods section (Fig. 2A and Table S1). In line with earlier results41, the titer of spores for the wild-type strain increased from 7.5 × 103 spores/ml at hour 12, to 1.0 × 104 spores/ml at hour 24, 1.3 × 105 spores/ml at hour 48 and 1.7 × 105 spores/ml at hour 72 (Fig. 2A and Table S1). As expected from the previous results, the CD25890 mutation did not affect cell viability (Table S1). In contrast, the titer of heat resistant spores in the mutant strain was higher than the wild-type for all time points: 3.1 × 104, 8.5 × 104 spores/mL, 1.5 × 106 and 2.2 × 106 spores/mL at hour 12, 24, 48 and 72, respectively (Fig. 2A and Table S1). The complemented CD25890c strain restored the wild-type kinetics of spore formation (1.8 × 104, 1.5 × 104, 7.8 × 104 and 6.0 × 104 spores/ml at hour 12, 24, 48 and 72, respectively; Fig. 2A and Table S1). Thus, deletion of CD25890 is responsible for the increased sporulation frequency of the mutant.
Another frequently used method to examine sporulation is growth on agar plates of 70:30 medium, in which the rate of sporulation is higher than in the SM broth used above43. We tested the sporulation efficiency of the CD25890 mutant in this medium. When sporulation was induced on 70:30 plates, the CD25890 mutant showed a percentage of sporulation similar to the wild-type strain (Fig. S4A). Thus, the culture medium influences the CD25890 mutant phenotype (see also below).
We next followed the morphological stages of sporulation in SM medium by phase-contrast and fluorescence microscopy41. The wild-type and the mutant strain were grown in SM and samples were collected 8, 10, 12, 14, 16, 18 and 20 h after inoculation. The cells were stained with FM4-64 prior to microscopic examination. Cells representative of several distinctive morphological classes are shown on Fig. 2B. We observed that 8 h after inoculation, a significant fraction of the CD25890 cells already processed polar division (Fig. 2C; class a). In contrast, class a cells were detected for the wild-type strain 2 h later than in the mutant. Moreover, phase bright spores (class e) were observed at 14 h for the mutant and at 18 h for the wild-type strain (Fig. 2C).
To test whether spore morphogenesis proceeded faster in the CD25890 mutant, we determined the time at which at least 10% of the cell population completed polar division (class a), initiated engulfment (class b), showed complete engulfment of the forespore by the mother cell (class c), or presented phase-gray or phase-bright spores (classes d and f). The results in Fig. 2D show that progress through these stages of sporulation occurred at the same pace for both strains. We conclude that the CD25890 mutant initiated sporulation earlier than the parental wild-type or that the fraction of cells entering sporulation at the end of growth is greater for the mutant. In any event, CD25890 negatively influenced the entry into sporulation.
CD25890 accumulates during growth independently of Spo0A
We further investigated accumulation of CD25890 during growth and sporulation in SM broth by immunoblot analysis using an anti-CD25890 antibody (Fig. 3A). CD25890 started to accumulate early during growth and was present during entry into stationary phase when the cells start to sporulate. No signal was detected in the CD25890 mutant, while its accumulation was restored in the complementation strain, confirming the specificity of the antibody. CD25890 accumulation was independent of Spo0A (Fig. 3B). Thus, CD25890 starts to accumulate during vegetative growth, independently of the main transcriptional regulator for entry into sporulation, Spo0A.
Deletion of CD25890 results in increased accumulation of Spo0A
The role of Spo0A in governing entry into sporulation in C. difficile has been established13,18,32. We wanted to test if deletion of CD25890 increased expression of the spo0A gene. We constructed a fusion of the spo0A promotor region to the SNAPCd reporter and we introduced the Pspo0A-SNAPCd fusion in the CD25890 mutant and in the parental wild-type strain (Table S5). To monitor production of the SNAPCd reporter, samples of cultures bearing the transcriptional fusion were collected 10 h after inoculation in SM and the cells were labelled with TMR-Star (Fig. 4A). SNAP production from Pspo0A-SNAPCd was detected in 100% of the cells for both the wild-type and the CD25890 mutant (Fig. 4A). Quantification of the fluorescence signal per cell (in arbitrary units, or AU; Fig. 4B), however, shows that transcription from the spo0A promoter occurred at a lower intensity in the wild-type (average signal, 137.6 arbitrary units, AU) compared to the CD25890 mutant (average signal, 277.3 AU) (Fig. 4B).
To investigate whether the increased transcription from the spo0A promoter could also lead to increased accumulation of Spo0A, we compared the levels of Spo0A throughout sporulation by immunoblot analysis using a previously described anti-Spo0A antibody (44; Fig. 4C). We detected Spo0A as early as 6 h following inoculation in SM for all strains. Quantification of band intensity however, shows that in the CD25890 mutant Spo0A accumulated at higher levels than in the wild-type or in the complementation strain at hours 6 (8 to 10 times more) and 8 (4 to 2 times more) (Fig. 4C,D). Together, these results suggest that in the mutant, more cells reach a threshold level of Spo0A that triggers sporulation. Moreover, since spo0A is subject to positive auto-regulation32, the results also suggest that CD25890 antagonizes the expression of spo0A and/or the activity of Spo0A.
Since we did not observe a phenotype for the CD25890 mutant when sporulation was induced on 70:30 medium (see above), we compared the expression of spo0A in SM broth to 70:30 medium using fluorescence microscopy and single cell analysis (Fig. S4B). Quantification of the fluorescence signal per cell (Fig. S4B) showed that transcription from the spo0A promoter was higher on 70:30 medium in both the wild-type (average signal, 267.1 AU) and CD25890 mutant (average signal, 332.8 AU), reaching levels similar to those observed in the mutant when sporulation was induced in SM (average signal, 372 AU) (Fig. S4B). This result suggests that on 70:30 plates, the wild-type strain reaches the threshold levels of spo0A required for sporulation in a higher number of cells than in SM broth, similar to what was observed for the CD25890 mutant in SM. Hence, under certain nutritional conditions, CD25890 acts to curtail sporulation initiation.
Phosphorylated Spo0A accumulates at higher levels in the CD25890 mutant
Spo0A is activated by phosphorylation45,46. The activated Spo0A ~ P, binds to DNA promoter regions containing a Spo0A-binding motif and regulates the expression of Spo0A-dependent genes. Since spo0A is auto-regulatory, and higher expression per cell was seen in the CD25890 mutant in SM, we asked whether Spo0A ~ P would accumulate at higher levels in the mutant. We used Phos-tag SDS-PAGE, where migration of Spo0A ~ P is delayed, and the two forms (phosphorylated and unphosphorylated) are detected by western blot using anti-Spo0A antibodies. The wild-type and the mutant strain were grown in SM and samples were collected 6, 8, 10 and 12 h after inoculation. Whole cell extracts were prepared and the proteins resolved by Phos-tag SDS-PAGE (Fig. 5A). Two bands were detected in this manner. The upper band disappeared when the samples were boiled prior to electrophoretic resolution, which indicates that the upper band corresponds to Spo0A ~ P and the lower band to the unphosphorylated form47. In the CD25890 mutant, both forms of Spo0A accumulate earlier and at higher levels than in the wild-type (Fig. 5A). We then quantified band intensities in order to estimate the ratio of the phosphorylated to unphosphorylated form of Spo0A (Spo0A∼P/Spo0A). The Spo0A∼P/Spo0A ratio was higher at hour 8 and 10 in the mutant as compared to the wild-type strain (Fig. 5B). At hour 12, however, the ratio between the two forms was similar between the two strains.
Together with the observation that spo0A is expressed in most if not all of the pre-divisional cells (Fig. 4A), this result suggests that the level of Spo0A phosphorylation correlates with the level of the protein. Ultimately, the level of spo0A per cell may limit entry into sporulation.
Deletion of CD25890 increases transcription of spo0A
Since there is a positive feedback loop in which Spo0A∼P controls spo0A transcription32, we cannot discriminate if the increased sporulation in the mutant could be due to increased transcription or to increased activity of Spo0A. To uncouple transcription from activation of Spo0A by phosphorylation, we placed the spo0A gene under the control of the anhydrotetracycline (ATc) responsive Ptet promoter48. This experimental setup allows Spo0A to accumulate to similar levels in the wild-type and in the CD25890 mutant strain, and to test whether Spo0A ~ P accumulated to a higher level in the mutant. The strains were grown in SM supplemented with 50 nM of ATc, a concentration at which Spo0A accumulates to levels similar to the wild-type strain48, and proteins in whole cells extracts were resolved by Phos-tag SDS-PAGE (Fig. 5C). In both strains Spo0A accumulated at similar levels and the Spo0A ~ P/Spo0A ratio was similar (Fig. 5C,D). In agreement with this observation, we found no difference in the titer of heat resistant spores produced by both strains (Table S2).
These results suggest that CD25890 acts to decrease the levels of spo0A transcription per cell. Since CD25890 has a putative DNA-binding domain (DUF 1732; Fig. 1), this effect may be direct or indirect.
Deletion of CD25890 influences the expression of the sinRR’ operon
To determine whether the CD25890 mutation had a more generalized effect on gene expression, we decided to compare the transcriptome of the mutant with the wild type after 10 h of growth in SM. We used two biological replicates and genes were considered differentially expressed if the fold change was > 2 and the adjusted p value < 0.01. 165 genes were overexpressed in the mutant, while only 21 genes were down-regulated (Table S3). From the upregulated genes, 69% of genes are regulated by Spo0A or by sporulation-specific cell type-specific sigma factors (Fig. 6A and Table S3). In contrast, no sporulation genes were found among the downregulated genes (Table S3). No toxin, biofilm or motility genes were among the genes differentially expressed in the CD25890 mutant (Table S3). However, the sinRR’ operon showed increased expression in the CD25890 mutant (~ fivefold, relative to the wild type; Table S3). The sinRR’ operon was previously shown to be involved in sporulation, toxin production and motility25. Overexpression of sinR increased sporulation efficiency, while overexpression of sinR’ reduced sporulation25. To our knowledge, however, the effect on sporulation of overexpression of the entire operon was not tested. To test the effect of overexpression of the sinRR’ operon, a plasmid containing the sinRR’ operon under the tetracycline-inducible promoter was introduced into the wild-type strain and the CD25890 mutant and sporulation was tested upon induction with ATc (Fig. 6B and Table S4). The same strains with the empty vector were used as a control in this assay. Sporulation assays were performed in bacterial cultures grown in SM supplemented with 50 ng/ml of ATc for 24 h. Overexpression of the sinRR’ operon in a wild type strain increased sporulation efficiency ~ 3.4—fold when compared to the wild-type control strain (Fig. 6B and Table S4). A similar increase relative to the wild-type was observed in the CD25890 mutant carrying the empty vector (~ 3.46 -fold). No significant effect on sporulation was observed when sinRR’ was overexpressed in a CD25890 mutant compared to the mutant control strain (Fig. 6B and Table S4). Therefore, overexpression of the sinRR’ operon leads to increased sporulation efficiency. In the CD25890 mutant background, however, overexpression of sinRR’ did not have a cumulative effect on spore production, suggesting that both alleles may act in the same pathway, leading to increased spo0A transcription.
Among the genes whose expression is independent of Spo0A, but exhibit differential expression in the CD25890 mutant, we identified putative transcriptional regulators that are upregulated in the mutant strain (CD21430 and CD24890), or downregulated (CD03700) (Table S3). It is tempting to speculate that CD25890 could act on spo0A and sinRR’ through the action of these Spo0A-independent regulators.
Virulence and colonization of the ∆CD25890 mutant in an animal model
Since the ∆CD25890 mutant exhibited increased sporulation frequency in vitro, we decided to investigate the function of CD25890 in sporulation in the intestine and its effect on pathogenesis in the acute Golden Syrian hamster model of infection. Male and female Syrian golden hamsters were infected by oral gavage with approximately 5,000 spores of the parent strain 630 erm, the ∆CD25890 mutant or the complemented strain, CD25890c. Following inoculation, animals were monitored for disease symptoms and fecal samples were collected every 24 h post-infection for enumeration of C. difficile. As shown in Fig. 7A, no significant difference was observed for the average time of post challenge survival between hamsters infected with the wild-type and the ∆CD25890 mutant strain (wild-type 56.6 ± 8.2; ∆CD25890 48.7 ± 4.5). Moreover, C. difficile CFU counts were similar in the cecal contents of the ∆CD25890 mutant and parental strain of infected animals post-mortem (Fig. 7B). These data indicate that despite the fact that the ∆CD25890 mutant had a higher sporulation frequency in vitro, CD25890 has no statistically significant effect on the virulence in the infection model.
Discussion
A genomic signature of sporulation in the human intestinal microbiome includes not only genes with an established function in sporulation (Fig. S1B) but also a group of 20 genes of unknown function1. We hypothesized that these uncharacterized genes may be important for sporulation. Here, we constructed an in-frame deletion mutation of one identified gene, CD25890, and characterized the resulting mutant. We show that the CD25890 protein accumulates during growth and stationary phase in SM medium in which sporulation is induced (Fig. 3). In agreement with our prediction, we found that under certain culturing conditions, deletion of CD25890 impacts sporulation. The CD25890 mutant reaches a higher titer of spores than the wild type strain when grown in sporulation medium (SM) and we show that in the mutant, spore differentiation is triggered in a larger fraction of the population (Fig. 2). The CD25890 mutant maintains high levels of spo0A expression and shows higher expression of genes required for sporulation (Fig. 4 and Fig. 6 and Table S3). Since Spo0A is auto-regulatory, the transcriptional fusion reports both transcription of spo0A as well as the activity of Spo0A which is activated via phosphorylation32. We show that Spo0A ~ P accumulates to higher levels in the CD25890 mutant earlier during growth, leading to increased expression of Spo0A-dependent genes. Uncoupling of transcription from activation by using an inducible promoter to control spo0A expression showed that CD25890 does not act on the phosphorylation status of Spo0A but rather at the level of spo0A transcription (Fig. 5).
Our finding that higher accumulation of Spo0A correlates with enhanced sporulation contrasts with studies performed in B. subtilis, where accelerated accumulation of Spo0A independent of the phosphorelay is detrimental to sporulation49,50. Rather, Spo0A needs to accumulate in a gradual manner to trigger sporulation and this requires its phosphorylation through the phosphorelay49. Thus, a gradual build-up of Spo0A ~ P may not be important for efficient sporulation in C. difficile. Previous studies have already shown that spo0A expression can be increased from an ATc-inducible promoter in a dose-dependent manner, and that the level of expression correlates with sporulation efficiency, which reaches values higher than those observed in a congenic wild-type strain48.
The impact of CD25890 on sporulation and on the expression of sporulation-specific genes is seen in SM broth but not on 70:30 agar medium. Notably, SM is mainly rich in amino acids42. Interestingly, the ability of C. difficile to metabolize amino acids via Stickland fermentation appears important for the colonization of some perturbed communities51,52. An amino acid rich medium may permit C. difficile to grow and multiply, delaying entering in sporulation. It is tempting to suggest that CD25890 would repress entry into sporulation in response to amino acid availability, but this remains to be tested (see also below). Conversely, 70:30 medium43 contains BHI, a more complex medium, possibly closer to the nutrient landscape of a healthy gut in which C. difficile is not able to proliferate; sporulation would then be a resort to persist within the host. As a strict anaerobe, C. difficile relies on spore formation for transmission between hosts but spores may also be a factor in persistence in the host and the immediate environment10. Sporulation appears to be an important function of the gut microbiota as about 60–70% of the organisms found in the gut are anaerobic spore formers10. Importantly, B. subtilis gastro-intestinal isolates tune the phosphorelay to favour sporulation, illustrating the importance of sporulation in the gut environment44,53.
Although our knowledge of the regulatory networks that control sporulation initiation in C. difficile is still incomplete, several lines of evidence suggest a direct link to the availability of nutrients in the environment. Two global regulators known to respond to nutrient availability in C. difficile are CodY and CcpA21–23,25. Both regulators affect the initiation of sporulation by repressing the expression of sporulation-related genes, such as the sinRR’ operon, in response to glucose and branched chain amino acids, respectively21–25. In C. difficile, SinR has a positive effect on sporulation, perhaps by elevating the expression of spo0A by an unknown mechanism25. Accordingly, in strain 630, a codY mutant shows increased sporulation24. The activity of CodY may be regulated through the intracellular level of branched-chain amino acids, and the pools of these amino acids appear to be influenced by the oligopeptide permeases, Opp and App24. Disruption of opp and app results in increased sporulation-specific gene expression and a hyper-sporulation phenotype20. One possibility is that Opp and App function to import peptides that increase the pool of branched-chain amino acids, thereby activating CodY and leading to repression of sinRR´ and of sporulation24. In a striking parallel with the opp-app and codY mutants, disruption of the CD25890 gene also results in increased sporulation-specific gene expression and a hyper-sporulation phenotype. Moreover, expression of the sinRR’ operon is also elevated in the CD25890 mutant (Table S3). It thus seems plausible that the hyper-sporulation phenotype seen in the CD25890 mutant also stems, at least in part, from increased expression of sinRR´ (Fig. 8). It was previously observed that when expressed from its native promoter, sinR’ transcripts levels were always reduced compared to sinR transcripts25. We suggest that when expression of the operon is increased, SinR levels are in greater abundance relative to SinR’, resulting in increased sporulation. It remains unknown whether opp-app/codY and CD25890 function in the same or in different pathways that converge on sinRR´. However, while CodY and CcpA also repress the expression of toxin-encoding genes21, the expression of CodY and CcpA targets are not significantly changed in the CD25890 mutant as determined by RNA-seq (Table S3). Thus, CodY and CcpA may not be involved in the same pathway as CD25890. In addition, opp-app mutants hyper-sporulate in 70:30 medium20, where disruption of CD25890 has no effect on sporulation. More work is required to unravel the regulatory network involving opp/app, codY, CD25890 and other factors that modulate sporulation initiation in C. difficile. Regardless, our analysis of the CD25890 mutant reinforces the idea that a direct link exists between the nutritional potential of the environment and sporulation initiation20–25.
The presence of a C-terminal domain (DUF1732) (36; Fig. 1B) suggests that CD25890 could function as a transcriptional regulator. It remains to be tested whether CD25890 binds to spo0A and sinRR regulatory regions. Two putative transcriptional regulators are upregulated in the CD25890 mutant, CD21430 (XRE-family like protein) and CD24890 (transcriptional regulator of the fructose PTS operon) while one is downregulated, CD03700 (also a XRE-family like protein) (Table S3). Whether increased expression of CD21430 or CD24890, or the diminished expression of CD03700 is the cause of the increased expression of sinRR’ and/or spo0A in the CD25890 mutant remains to be tested.
In all, our analysis shows that the genomic signature of sporulation within the human intestinal microbiome can be used to identify new genes important during the sporulation process. Further studies are needed to established the function of the other signature genes. This may lead to the identification of new genetic determinants for spore formation whose products could act as important targets for the design of drugs effective against spore-forming bacteria.
Materials and methods
Growth conditions and general methods
Bacterial strains and their relevant properties are listed in Table S5. The Escherichia coli strain DH5α (Bethesda Research laboratories) was used for molecular cloning, while the strain HB101 (RP4) was used as the donor in C. difficile conjugation experiments54. Luria–Bertani medium was routinely used for growth and maintenance of E. coli. When appropriate, ampicillin (100 µg/ml) or chloramphenicol (15 µg/ml) was added to the culture medium. The C. difficile strains used in this study are isogenic derivatives of the wild-type strain 630 erm54 and were routinely grown anaerobically (5% H2, 15% CO2, 80% N2) at 37ºC in brain heart infusion (BHI) medium (Difco)42. Assays for toxin production were done in tryptone yeast extract (30 g/L tryptone; 20 g/L yeast extract) (TY)40. When necessary, cefoxitin (25 µg/ml) and thiamphenicol (15 µg /ml) were added to C. difficile cultures. A defined minimal media (CDMM)55 with 1% agar was used as uracil-free medium when performing genetic selections. Growth kinetic parameters were calculated by fitting the growth curve using the logistic equation (see Eq. 1) which provides parameters like growth rate (µ) and the maximum population (ODmax or Ym). For curve fitting we used only the measurements between 5 and 12 h, which corresponds to the part of the growth curve that obeys to the logistic model.
1 |
Sporulation was tested in liquid Sporulation Medium (SM; for 1L: Bacto tryptone 90 g, Bacto peptone 5 g, (NH4)2SO4 1 g, Tris base 1.5 g, pH 7;42) and/or on 70:30 agar medium (for 1L: Bacto peptone 63 g, proteose peptone 3.5 g, (NH4)2SO4 0.7 g, Tris base 1.06 g, brain heart infusion extract 11.1 g, yeast extract 1.5 g, cysteine 0.3 g and agar 15 g;43). Sporulation was regularly induced by inoculating in SM liquid. To determine the total number of cells, the cells were serially diluted and plated on BHI with 0.1% taurocholate (Sigma-Aldrich) to ensure efficient spore germination. To determine the number of spores, the cells were heat killed by incubation for 30 min at 70 °C prior to plating on BHI with 0.1% taurocholate.
Construction of the CD25890 mutant
A CD25890 in-frame deletion mutant was generated using allele-couple exchange (ACE) in C. difficile 630 erm pyrE as described37. The homology regions upstream and downstream of the desired junction point within CD25890 were PCR-amplified and cloned into pMTL-YN3 as follows37. The upstream fragment (742 bp) was amplified using the primers CD25890_AscI_Fwd and CD25890_LHA_Rev and the downstream fragment (735 bp) was amplified using the primers CD25890_RHA_Fwd and CD25890_SbfI_Rev. The fragments were then joined by overlapping PCR, the resulting fragment cleaved with AscI and SbfI and cloned between the same sites of pMTL-YN3, yielding pAM37. This plasmid was introduced into E. coli HB101 (RP4) and then transferred to strain 630 erm pyrE by conjugation37. Following two passages on BHI agar supplemented with 25 µg/mL cefoxitin and 15 µg/mL thiamphenicol, colonies that were noticeably larger (indicative of plasmid integration) were screened by colony PCR to identify single-crossover mutants using primers flanking the upstream and downstream homology regions in conjunction with a plasmid-specific primer (P3 with P2 and P4 with P1) to amplify across the integration junction (Fig. S2). Clones positives for single crossover mutants were streaked onto C. difficile minimal medium (CDMM) supplemented with 5 µg/mL uracil and 2 mg/mL 5-fluoroorotic acid (FOA) to select for plasmid excision. The isolated FOA-resistant colonies were screened by PCR using primers P3 and P4. Double-crossover mutants, in which the mutant allele was successfully integrated yielded products smaller than those seen in WT revertants (1630 bp instead of 2472 bp). In order to restore the pyrE+ phenotype, plasmid pMTL-YN1 carrying the WT pyrE allele was conjugated into the isolated double-crossover mutants. The resulting colonies were restreaked onto non-supplemented CDMM agar to select for uracil prototrophy indicating successful allele exchange. Successful restoration of the WT pyrE allele was confirmed by colony PCR using primers flanking the pyrE locus (P5 and P6, Fig. S2).
In trans complementation of CD25890 mutant
To complement the CD25890 mutation the coding sequence and its expected promoter region were amplified by PCR using primers CD25890 _Fwd_BamHI and CD25890 _Rev_XhoI yielding a 1515 bp fragment. The fragment was then digested with BamHI and XhoI and inserted between the same sites of pMTL-YN137, yielding pAM38. This plasmid was introduced into E. coli HB101 (RP4) and then transferred to strain 630 erm pyrE CD25890 by conjugation37. Following two passages on BHI agar supplemented with 25 µg/mL cefoxitin and 15 µg/mL thiamphenicol, colonies that were noticeably larger (indicative of plasmid integration) were streaked onto onto non-supplemented CDMM to select for uracil prototrophy indicating successful allele exchange. Successful restoration of the WT pyrE allele was confirmed by colony PCR using primers flanking the pyrE locus (P5 and P6, Fig. S2).
Construction of Ptet-sinRR’
To construct a Ptet-sinRR’ fusion, the sinRR’ operon was amplified by PCR using primers IMV503 and IMV505, yielding a 762 bp fragment. The fragment was then digested with BamHI and SacI and inserted between the same sites of pRPF18556, yielding pDIA5972.
Biofilm formation assays
For the biofilm assay, 1 ml of BHI-S medium containing 0.1 M glucose, 0.1% cysteine and DOC (240 M) was inoculated in a well of a 24-well microplate39. Microplates were incubated at 37 °C for 24 h. The biofilm was washed with PBS (Phosphate buffered saline), stained with 1 ml of crystal violet (0.2%) followed by two washes with PBS. The OD600nm was measured after resuspension of the cells in methanol/acetone using non-inoculated medium as a negative control.
SNAPCd transcriptional fusions
To construct transcriptional SNAPCd fusions to the spo0A promoter, a 568 bp DNA fragment containing the Spo0A promoter region was PCR-amplified using genomic DNA from strain 630∆erm and primer pairs CDspo0A_598_Fw/CDspo0A_SNAP_Rev. These fragments were cloned into pFT4741 to create pMS463 (Table S7). Plasmid pMS463 was transferred to 630∆erm, and congenic ∆CD25890 mutants by conjugation from derivatives of E. coli HB101 (RP4) (Table S5).
SNAP labelling, fluorescence microscopy and image analysis
Samples of 1 ml were withdrawn from SM cultures at the desired times following inoculation, and the cells collected by centrifugation (10 min, 4000xg, at 4ºC). The cells were washed with 1 ml of phosphate-buffered saline (PBS; 137 mM NaCl, 10 mM Phosphate, 2.7 mM KCl, pH 7.4), and resuspended in 0.1 ml of PBS supplemented with the lipophilic styryl membrane dye N-(3-triethylammoniumprpyl)-4-(p-diethylaminophenyl-hexatrienyl) pyridinium dibromide (FM4-64, Molecular Probes, Invitrogen; 10 g.ml−1)57. For SNAP labelling, TMR-Star was added to cells in culture samples inside an anaerobic chamber to a final concentration of 250 nM (New England Biolabs) and the mixture incubated for 30 min in the dark. Following labelling, the cells were collected by centrifugation (4000xg for 5 min), washed four times with 1 ml of PBS, and finally suspended in 10-20 μl of PBS. For phase contrast and fluorescence microscopy, cells were mounted on 1.7% agarose coated glass slides and observed on a Leica DM6000B microscope equipped with a phase contrast Uplan F1 100 × objective and captured with a CCD Andor Ixon camera (Andor Technologies). Images were acquired and analysed using the Metamorph software suite (version 5.8; Molecular Devices; URL: https://www.moleculardevices.com/products/cellular-imaging-systems/acquisition-and-analysis-software/metamorph-microscopy) and adjusted and cropped using Photoshop S4. Statistical analysis was carried out using GraphPad Prism (Version 7.0; GraphPad Software Inc.). The non-parametric Kolmogorov–Smirnov test (KS-test) was applied to compare distributions obtained from quantifications of the SNAP-TMR signal. The P-value is indicated for all comparisons whose differences were found to be statistically significant. Although the results presented are from a single experiment, all experiments involving quantification of a fluorescence signal were performed independently three times and only results that were considered statistically significant by a KS-test in all three experiments were considered to be statistically relevant.
His6-CD25890 overproduction purification and polyclonal antibody production
A DNA fragment encoding the CD25890 gene was generated by PCR from C. difficile 630∆erm genomic DNA using primers CD25890_BamHI_Fw/ CD25890_NotI_Rev. The resulting DNA fragment was cut with BamHI and NotI and cloned between the same sites of pETDuet-1 (Novagen) to produce pDM35. Plasmid pDM35 was introduced into BL21 (DE3) cells and the E. coli strain was grown in autoinduction medium. The cells were then harvested by centrifugation (4000 × g, for 10 min, at 4ºC) and the sediment resuspended in lysis buffer (20 mM phosphate pH7.4, 1 mM PMSF, 10 mM Imidazole). The suspension was lysed using a French pressure cell (at 18,000 lb/in2) and the lysate cleared by centrifugation (15,000 × g, 30 min at at 4ºC), and the supernantant was loaded onto a 1 ml Histrap column (Amersham Phamarcia Biotech). The bound protein was eluted with a discontinuous imidazole gradient and the fractions containing His6-CD25890 were identified by SDS-PAGE. The antibody was produced by Eurogentec (Seraing, Belgium).
Preparation of C. difficile extracts and immunoblotting
Whole cell extracts were obtained by withdrawing 20 ml samples from SM or TY cultures of C. difficile 6, 8, 10 and 12 h of after inoculation. The cells were collected by centrifugation (4000xg, for 5 min at 4ºC), the cell sediment was washed with phosphate-buffered saline (PBS) and suspended in 1 ml French press buffer (10 mM Tris pH 8.0, 10 mM MgCl2, 0.5 mM EDTA, 0.2 mM NaCl, 10% Glycerol, 1 mM PMSF). The cells were lysed using a French pressure cell (18,000 lb/in2). Proteins in the extracts were resolved on 12% SDS-PAGE gels. Anti-CD25890 were used at a 1:1000 dilution, and an anti-rabbit secondary antibody conjugated to horseradish peroxidase (Sigma) was used at a 1:10,000 dilution. The monoclonal anti-TcdA primary antibody (Santa Cruz Biotechnology) were used at a 1:1000 dilution, and an anti-mouse secondary antibody conjugated to horseradish peroxidase (Sigma) was used at a 1:2000 dilution. The immunoblots were developed with enhanced chemiluminescence reagents (Amersham Pharmacia Biotech). Images were adjusted and cropped and quantified using ImageJ (http://rsbweb.nih.gov/ij/).
Detection of Spo0A phosphorylation using a Phos-tag acrylamide gel
Phos-tag acrylamide gels were prepared according to the instructions provided (Wako); 10% acrylamide gels were copolymerized with 25 nM Phos-tag acrylamide and 10 nM MnCl2. 20-ml of bacterial cultures were centrifuged at 5,000 g at 4 °C for 10 min, and the pellets suspended in 1 ml 10 mM Tris pH 8.0. The cells were lysed using a French pressure cell (18,000 lb/in2). Samples were stored on ice prior to loading onto Phos-tag acrylamide gels and run at 4 °C. Gels were fixed for 10 min in transfer buffer with 10 mM EDTA and then washed for 10 min in transfer buffer without EDTA twice. After transfer to a nitrocellulose membrane, the samples were probed with rabbit polyclonal anti-Spo0A or anti-FliC antibodies at a 1:1000 dilution and an anti-rabbit secondary antibody conjugated to horseradish peroxidase (Sigma) was used at dilution 1:10,000. Images were adjusted and cropped and quantified using ImageJ (http://rsbweb.nih.gov/ij/). In order to dephosphorylate Spo0A ~ P, samples were incubated at 100 °C for 5 min.
RNA extraction and RNA-sequencing
RNA for RNA-Seq was extracted from two independent biological replicates of WT and CD25890 mutant C. difficile strains, after 10 h of growth in SM, using a RNeasy Kit (Qiagen). Contaminating genomic DNA was depleted by two DNase treatments (Promega), according to manufacturer's recommendations. DNAse-treated RNA (5 µg) was mRNA enriched using a Ribo-Zero Magnetic Kit (Epicentre). After Illumina sequencing the reads were mapped to C. difficile 630 genome using Hisat. Statistical analyses were performed with DESeq2. A gene was considered differentially expressed when the fold change was > 2 and the adjusted p value was < 0.01.
Animal studies
Animals were euthanized in accordance with the Panel on Euthanasia of the American Veterinary Medical Association guidelines. All animal studies were performed with prior approval from the Emory University Institutional Animal Care and Use Committee (IACUC), and in compliance with the ARRIVE guidelines. Animal Infection studies were performed using the Syrian golden hamster model (Mesocricetus auratus) as previously described58. Briefly, 6–8 week old male and female hamsters were purchased from Charles River Laboratories and were housed in within an ABSL-2 facility in the Emory University Division of Animal Resources. Hamsters were housed in individual sterile cages and fed sterile water and rodent feed, ad libitum. Animals were administered 30 mg/kg clindamycin by oral gavage seven days before inoculation with approximately 5000 C. difficile spores, as indicated. Spores were prepared as previously described and stored in PBS solution with 1% BSA59,60. Prior to inoculation, spores were heated at 60 °C for 20 min and allowed to cool to room temperature before administering to animals by oral gavage. Following infection, animals were monitored at least once per day throughout the experiment for signs of disease. Hamsters were considered moribund when they became severely lethargic or had lost 15% or more of their maximum body weight. Fecal samples and animal weights were collected daily; cecal samples were collected post-mortem. Fecal and cecal contents were enumerated by plating on TCCFA medium42,61. Differences in survival times were statistically assessed by log-rank regression, while bacterial counts were evaluated using a one-way ANOVA with the Dunnett’s multiple-comparison test. Statistical analyses were performed using GraphPad Prism v.7 for Macintosh. Spores were decontaminated from workspace surfaces as previously described62.
qPCR
After 12 h of growth on 70:30 agar plates, cells from WT, CD25890, and CD25890C were harvested for RNA extraction and subsequent cDNA synthesis as previously described22,63. Harvested cells were mixed with a 1:1 ethanol: acetone solution and stored at -80C overnight. A total of 10ug of RNA was extracted and treated with DNAse I for synthesis of 1ug cDNA (PCR machine used). qPCR primers were generated using the IDT PrimerQuest Tool (Integrated DNA Technologies) and can be found in Table S6. qPCR reactions were carried out on a Roche LightCycler 96 instrument and performed in technical triplicate. For relative quantification, the Ct method was used to normalize dapF, CD25890, and gmk expression to that of the internal control, rpoC64.
Supplementary Information
Acknowledgments
This work was supported by the FCT (“Fundação para a Ciência e a Tecnologia") through program IF (IF/00268/2013/CP1173/CT0006) and award PTDC/BIA-MIC/29293/2017 to MS, by the European Union Marie Sklodowska Curie Innovative Training Networks (contract number 642068) to AOH and by awards 5R01AI116895 and 1U01AI124290 from the National Institute of Allergy and Infectious Diseases to SMB. This work was also financially supported by Project LISBOA-01-0145-FEDER-007660 (“Microbiologia Molecular, Estrutural e Celular”) funded by FEDER funds through COMPETE2020 – “Programa Operacional Competitividade e Internacionalização” (POCI) and partially supported by project ONEIDA (LISBOA-01-0145-FEDER-016417) co-funded by FEEI—"Fundos Europeus Estruturais e de Investimento" from "Programa Operacional Regional Lisboa 2020". ALM was the recipient of a PhD fellowship (PD/BD/105738/2014) within the scope of the PhD program Molecular Biosciences funded by FCT. DM is the recipient of a PhD fellowship (PD/BD/143148/2019) within the scope of the PhD program INTERFACE funded by FCT. This research was supported by the U.S. National Institutes of Health through research grants AI116933 and AI121684 to S.M.M., and GM 008490 to M.D. The content of the paper is solely the responsibility of the authors and does not necessarily reflect the official views of the National Institutes of Health.
Author contributions
D.M. designed and performed the experiments and analyzed the data. M.D. and A.L.M. performed experiments. D.W. and S.M.M. designed experiments, analyzed the data and revised the manuscript. A.O.H. participated in the discussion and interpretation of results, determination of the conclusions and revision of the manuscript. M.S. designed experiments, analyzed the data and wrote the manuscript.
Footnotes
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
The online version contains supplementary material available at 10.1038/s41598-021-86878-9.
References
- 1.Browne HP, et al. Culturing of 'unculturable' human microbiota reveals novel taxa and extensive sporulation. Nature. 2016;533:543–546. doi: 10.1038/nature17645. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Almeida A, et al. A new genomic blueprint of the human gut microbiota. Nature. 2019;568:499–504. doi: 10.1038/s41586-019-0965-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Atarashi K, et al. Induction of colonic regulatory T cells by indigenous Clostridium species. Science. 2011;331:337–341. doi: 10.1126/science.1198469. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Zhu D, Sorg JA, Sun X. Clostridioides difficile biology: sporulation, germination, and corresponding therapies for C. difficile infection. Front. Cell Infect. Microbiol. 2018;8:29. doi: 10.3389/fcimb.2018.00029. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Carroll KC, Bartlett JG. Biology of Clostridium difficile: implications for epidemiology and diagnosis. Annu. Rev. Microbiol. 2011;65:501–521. doi: 10.1146/annurev-micro-090110-102824. [DOI] [PubMed] [Google Scholar]
- 6.Martin JS, Monaghan TM, Wilcox MH. Clostridium difficile infection: epidemiology, diagnosis and understanding transmission. Nat. Rev. Gastroenterol. Hepatol. 2016;13:206–216. doi: 10.1038/nrgastro.2016.25. [DOI] [PubMed] [Google Scholar]
- 7.Abecasis AB, et al. A genomic signature and the identification of new sporulation genes. J. Bacteriol. 2013;195:2101–2115. doi: 10.1128/JB.02110-12. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Galperin MY, et al. Genomic determinants of sporulation in Bacilli and Clostridia: towards the minimal set of sporulation-specific genes. Environ. Microbiol. 2012;14:2870–2890. doi: 10.1111/j.1462-2920.2012.02841.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Traag BA, Pugliese A, Eisen JA, Losick R. Gene conservation among endospore-forming bacteria reveals additional sporulation genes in Bacillus subtilis. J. Bacteriol. 2013;195:253–260. doi: 10.1128/JB.01778-12. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Deakin LJ, et al. The Clostridium difficile spo0A gene is a persistence and transmission factor. Infect. Immun. 2012;80:2704–2711. doi: 10.1128/IAI.00147-12. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Fujita M, Gonzalez-Pastor JE, Losick R. High- and low-threshold genes in the Spo0A regulon of Bacillus subtilis. J. Bacteriol. 2005;187:1357–1368. doi: 10.1128/JB.187.4.1357-1368.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Molle V, et al. The Spo0A regulon of Bacillus subtilis. Mol. Microbiol. 2003;50:1683–1701. doi: 10.1046/j.1365-2958.2003.03818.x. [DOI] [PubMed] [Google Scholar]
- 13.Pettit LJ, et al. Functional genomics reveals that Clostridium difficile Spo0A coordinates sporulation, virulence and metabolism. BMC Genom. 2014;15:160. doi: 10.1186/1471-2164-15-160. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Sonenshein AL. Control of sporulation initiation in Bacillus subtilis. Curr. Opin. Microbiol. 2000;3:561–566. doi: 10.1016/s1369-5274(00)00141-7. [DOI] [PubMed] [Google Scholar]
- 15.Jiang M, Shao W, Perego M, Hoch JA. Multiple histidine kinases regulate entry into stationary phase and sporulation in Bacillus subtilis. Mol. Microbiol. 2000;38:535–542. doi: 10.1046/j.1365-2958.2000.02148.x. [DOI] [PubMed] [Google Scholar]
- 16.Higgins D, Dworkin J. Recent progress in Bacillus subtilis sporulation. FEMS Microbiol. Rev. 2012;36:131–148. doi: 10.1111/j.1574-6976.2011.00310.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Steiner E, et al. Multiple orphan histidine kinases interact directly with Spo0A to control the initiation of endospore formation in Clostridium acetobutylicum. Mol. Microbiol. 2011;80:641–654. doi: 10.1111/j.1365-2958.2011.07608.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Underwood S, et al. Characterization of the sporulation initiation pathway of Clostridium difficile and its role in toxin production. J. Bacteriol. 2009;191:7296–7305. doi: 10.1128/JB.00882-09. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Childress KO, et al. The Phosphotransfer Protein CD1492 Represses Sporulation Initiation in Clostridium difficile. Infect. Immun. 2016;84:3434–3444. doi: 10.1128/IAI.00735-16. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Edwards AN, Nawrocki KL, McBride SM. Conserved oligopeptide permeases modulate sporulation initiation in Clostridium difficile. Infect. Immun. 2014;82:4276–4291. doi: 10.1128/IAI.02323-14. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Antunes A, et al. Global transcriptional control by glucose and carbon regulator CcpA in Clostridium difficile. Nucl. Acids Res. 2012;40:10701–10718. doi: 10.1093/nar/gks864. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Dineen SS, McBride SM, Sonenshein AL. Integration of metabolism and virulence by Clostridium difficile CodY. J. Bacteriol. 2010;192:5350–5362. doi: 10.1128/JB.00341-10. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Dineen SS, Villapakkam AC, Nordman JT, Sonenshein AL. Repression of Clostridium difficile toxin gene expression by CodY. Mol. Microbiol. 2007;66:206–219. doi: 10.1111/j.1365-2958.2007.05906.x. [DOI] [PubMed] [Google Scholar]
- 24.Nawrocki KL, Edwards AN, Daou N, Bouillaut L, McBride SM. CodY-Dependent Regulation of Sporulation in Clostridium difficile. J. Bacteriol. 2016;198:2113–2130. doi: 10.1128/JB.00220-16. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Girinathan BP, Ou J, Dupuy B, Govind R. Pleiotropic roles of Clostridium difficile sin locus. PLoS Pathog. 2018;14:e1006940. doi: 10.1371/journal.ppat.1006940. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Koide A, Hoch JA. Identification of a second oligopeptide transport system in Bacillus subtilis and determination of its role in sporulation. Mol. Microbiol. 1994;13:417–426. doi: 10.1111/j.1365-2958.1994.tb00436.x. [DOI] [PubMed] [Google Scholar]
- 27.Perego M, Higgins CF, Pearce SR, Gallagher MP, Hoch JA. The oligopeptide transport system of Bacillus subtilis plays a role in the initiation of sporulation. Mol. Microbiol. 1991;5:173–185. doi: 10.1111/j.1365-2958.1991.tb01838.x. [DOI] [PubMed] [Google Scholar]
- 28.Fimlaid KA, et al. Global analysis of the sporulation pathway of Clostridium difficile. PLoS Genet. 2013;9:e1003660. doi: 10.1371/journal.pgen.1003660. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Dawson LF, Valiente E, Faulds-Pain A, Donahue EH, Wren BW. Characterisation of Clostridium difficile biofilm formation, a role for Spo0A. PLoS ONE. 2012;7:e50527. doi: 10.1371/journal.pone.0050527. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Errington J. Regulation of endospore formation in Bacillus subtilis. Nat. Rev. Microbiol. 2003;1:117–126. doi: 10.1038/nrmicro750. [DOI] [PubMed] [Google Scholar]
- 31.Piggot PJ, Hilbert DW. Sporulation of Bacillus subtilis. Curr. Opin. Microbiol. 2004;7:579–586. doi: 10.1016/j.mib.2004.10.001. [DOI] [PubMed] [Google Scholar]
- 32.Rosenbusch KE, Bakker D, Kuijper EJ, Smits WK. C. Difficile 630Deltaerm Spo0A regulates sporulation, but does not contribute to toxin production, by direct high-affinity binding to target DNA. PLoS ONE. 2012;7:e48608. doi: 10.1371/journal.pone.0048608. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Jensen LJ, et al. STRING 8–a global view on proteins and their functional interactions in 630 organisms. Nucl. Acids Res. 2009;37:D412–416. doi: 10.1093/nar/gkn760. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Winkelman JT, Blair KM, Kearns DB. RemA (YlzA) and RemB (YaaB) regulate extracellular matrix operon expression and biofilm formation in Bacillus subtilis. J Bacteriol. 2009;191:3981–3991. doi: 10.1128/JB.00278-09. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Poulsen P, Jensen KF. Three genes preceding pyrE on the Escherichia coli chromosome are essential for survival and normal cell morphology in stationary culture and at high temperature. Res. Microbiol. 1991;142:283–288. doi: 10.1016/0923-2508(91)90042-9. [DOI] [PubMed] [Google Scholar]
- 36.Rigden DJ. Ab initio modeling led annotation suggests nucleic acid binding function for many DUFs. OMICS. 2011;15:431–438. doi: 10.1089/omi.2010.0122. [DOI] [PubMed] [Google Scholar]
- 37.Ng YK, et al. Expanding the repertoire of gene tools for precise manipulation of the Clostridium difficile genome: allelic exchange using pyrE alleles. PLoS ONE. 2013;8:e56051. doi: 10.1371/journal.pone.0056051. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Cuenot E, et al. The Ser/Thr Kinase PrkC Participates in Cell Wall Homeostasis and Antimicrobial Resistance in Clostridium difficile. Infect. Immun. 2019;87:1. doi: 10.1128/IAI.00005-19. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Dubois T, et al. A microbiota-generated bile salt induces biofilm formation in Clostridium difficile. NPJ Biofilms Microbiomes. 2019;5:14. doi: 10.1038/s41522-019-0087-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Fang A, Gerson DF, Demain AL. Production of Clostridium difficile toxin in a medium totally free of both animal and dairy proteins or digests. Proc. Natl. Acad. Sci. USA. 2009;106:13225–13229. doi: 10.1073/pnas.0906425106. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Pereira, F. C. et al. The spore differentiation pathway in the enteric pathogen Clostridium difficile. PLoS Genet (2013). [DOI] [PMC free article] [PubMed]
- 42.Wilson KH, Kennedy MJ, Fekety FR. Use of sodium taurocholate to enhance spore recovery on a medium selective for Clostridium difficile. J. Clin. Microbiol. 1982;15:443–446. doi: 10.1128/JCM.15.3.443-446.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Putnam EE, Nock AM, Lawley TD, Shen A. SpoIVA and SipL are Clostridium difficile spore morphogenetic proteins. J. Bacteriol. 2013;195:1214–1225. doi: 10.1128/JB.02181-12. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Serra CR, Earl AM, Barbosa TM, Kolter R, Henriques AO. Sporulation during growth in a gut isolate of Bacillus subtilis. J. Bacteriol. 2014;196:4184–4196. doi: 10.1128/JB.01993-14. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Fujita M, Sadaie Y. Feedback loops involving Spo0A and AbrB in in vitro transcription of the genes involved in the initiation of sporulation in Bacillus subtilis. J. Biochem. 1998;124:98–104. doi: 10.1093/oxfordjournals.jbchem.a022103. [DOI] [PubMed] [Google Scholar]
- 46.Lewis RJ, Brannigan JA, Muchova K, Barak I, Wilkinson AJ. Phosphorylated aspartate in the structure of a response regulator protein. J. Mol. Biol. 1999;294:9–15. doi: 10.1006/jmbi.1999.3261. [DOI] [PubMed] [Google Scholar]
- 47.Yasugi M, et al. Transcriptional Profile during Deoxycholate-Induced Sporulation in a Clostridium perfringens Isolate Causing Foodborne Illness. Appl. Environ. Microbiol. 2016;82:2929–2942. doi: 10.1128/AEM.00252-16. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Dembek M, et al. Inducible Expression of spo0A as a Universal Tool for Studying Sporulation in Clostridium difficile. Front. Microbiol. 2017;8:1793. doi: 10.3389/fmicb.2017.01793. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Fujita M, Losick R. Evidence that entry into sporulation in Bacillus subtilis is governed by a gradual increase in the level and activity of the master regulator Spo0A. Genes. Dev. 2005;19:2236–2244. doi: 10.1101/gad.1335705. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Vishnoi M, et al. Triggering sporulation in Bacillus subtilis with artificial two-component systems reveals the importance of proper Spo0A activation dynamics. Mol. Microbiol. 2013;90:181–194. doi: 10.1111/mmi.12357. [DOI] [PubMed] [Google Scholar]
- 51.Fletcher, J. R., Erwin, S., Lanzas, C. & Theriot, C. M. Shifts in the Gut Metabolome and clostridium difficile transcriptome throughout colonization and infection in a mouse Model. mSphere. 10.1128/mSphere.00089-18 (2018). [DOI] [PMC free article] [PubMed]
- 52.Janoir C, et al. Adaptive strategies and pathogenesis of Clostridium difficile from in vivo transcriptomics. Infect. Immun. 2013;81:3757–3769. doi: 10.1128/IAI.00515-13. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Tam NK, et al. The intestinal life cycle of Bacillus subtilis and close relatives. J. Bacteriol. 2006;188:2692–2700. doi: 10.1128/JB.188.7.2692-2700.2006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54.Hussain HA, Roberts AP, Mullany P. Generation of an erythromycin-sensitive derivative of Clostridium difficile strain 630 (630Deltaerm) and demonstration that the conjugative transposon Tn916DeltaE enters the genome of this strain at multiple sites. J. Med. Microbiol. 2005;54:137–141. doi: 10.1099/jmm.0.45790-0. [DOI] [PubMed] [Google Scholar]
- 55.Karasawa T, Ikoma S, Yamakawa K, Nakamura S. A defined growth medium for Clostridium difficile. Microbiology. 1995;141(Pt 2):371–375. doi: 10.1099/13500872-141-2-371. [DOI] [PubMed] [Google Scholar]
- 56.Fagan RP, Fairweather NF. Clostridium difficile has two parallel and essential Sec secretion systems. J. Biol. Chem. 2011;286:27483–27493. doi: 10.1074/jbc.M111.263889. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57.Pogliano J, et al. A vital stain for studying membrane dynamics in bacteria: a novel mechanism controlling septation during Bacillus subtilis sporulation. Mol. Microbiol. 1999;31:1149–1159. doi: 10.1046/j.1365-2958.1999.01255.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58.Edwards AN, Tamayo R, McBride SM. A novel regulator controls Clostridium difficile sporulation, motility and toxin production. Mol. Microbiol. 2016;100:954–971. doi: 10.1111/mmi.13361. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59.Edwards AN, McBride SM. Isolating and Purifying Clostridium difficile Spores. Methods Mol. Biol. 2016;1476:117–128. doi: 10.1007/978-1-4939-6361-4_9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60.Woods EC, Nawrocki KL, Suarez JM, McBride SM. The Clostridium difficile Dlt Pathway Is Controlled by the Extracytoplasmic Function Sigma Factor sigmaV in Response to Lysozyme. Infect. Immun. 2016;84:1902–1916. doi: 10.1128/IAI.00207-16. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61.George WL, Sutter VL, Citron D, Finegold SM. Selective and differential medium for isolation of Clostridium difficile. J. Clin. Microbiol. 1979;9:214–219. doi: 10.1128/jcm.9.2.214-219.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62.Woods EC, Edwards AN, Childress KO, Jones JB, McBride SM, The C. difficile clnRAB operon initiates adaptations to the host environment in response to LL-37. PLoS Pathog. 2018;14:e1007153. doi: 10.1371/journal.ppat.1007153. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 63.Suarez JM, Edwards AN, McBride SM. The Clostridium difficile cpr locus is regulated by a noncontiguous two-component system in response to type A and B lantibiotics. J. Bacteriol. 2013;195:2621–2631. doi: 10.1128/JB.00166-13. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 64.Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative C(T) method. Nat. Protoc. 2008;3:1101–1108. doi: 10.1038/nprot.2008.73. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.